Insider Selling: OrthoPediatrics (NASDAQ:KIDS) Major Shareholder Sells $234,026.10 in Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) major shareholder Jennifer Pritzker sold 10,131 shares of the company’s stock in a transaction dated Tuesday, September 1st. The shares were sold at an average price of $23.10, for a total transaction of $234,026.10. Following the completion of the transaction, the insider owned 6,526,633 shares in the company, valued at $150,765,222.30. This trade represents a 0.15% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Large shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

OrthoPediatrics Stock Performance

NASDAQ:KIDS traded down $0.31 during mid-day trading on Tuesday, reaching $23.00. 139,797 shares of the company’s stock were exchanged, compared to its average volume of 173,766. OrthoPediatrics Corp. has a one year low of $14.42 and a one year high of $26.74. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.17 and a current ratio of 4.78. The business’s fifty day simple moving average is $21.52 and its two-hundred day simple moving average is $18.72. The firm has a market capitalization of $600.53 million, a PE ratio of -13.69 and a beta of 0.98.

OrthoPediatrics (NASDAQ:KIDS) last posted its quarterly earnings data on Tuesday, August 4th. The company reported ($0.26) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.30) by $0.04. OrthoPediatrics had a negative net margin of 15.72% and a negative return on equity of 8.10%. The firm had revenue of $70.51 million during the quarter, compared to the consensus estimate of $68.21 million. Analysts anticipate that OrthoPediatrics Corp. will post -1.14 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on KIDS. Piper Sandler reissued an “overweight” rating and set a $25.00 price target (up from $22.00) on shares of OrthoPediatrics in a research report on Wednesday, August 5th. TD Cowen reaffirmed a “buy” rating on shares of OrthoPediatrics in a report on Monday, June 15th. Needham & Company LLC upped their target price on OrthoPediatrics from $30.00 to $35.00 and gave the company a “buy” rating in a research report on Wednesday, August 5th. Truist Financial set a $22.00 target price on OrthoPediatrics in a report on Wednesday, August 5th. Finally, BTIG Research raised their price target on OrthoPediatrics from $24.00 to $29.00 and gave the stock a “buy” rating in a research report on Thursday, August 20th. Nine research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $26.44.

Institutional Trading of OrthoPediatrics

Institutional investors and hedge funds have recently made changes to their positions in the company. Russell Investments Group Ltd. boosted its position in shares of OrthoPediatrics by 433.1% during the 3rd quarter. Russell Investments Group Ltd. now owns 1,402 shares of the company’s stock worth $26,000 after acquiring an additional 1,139 shares in the last quarter. Legal & General Group Plc bought a new position in OrthoPediatrics in the second quarter valued at approximately $34,000. Northwestern Mutual Wealth Management Co. grew its position in OrthoPediatrics by 5,226.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 2,610 shares of the company’s stock valued at $46,000 after acquiring an additional 2,561 shares during the last quarter. Caption Management LLC bought a new position in OrthoPediatrics in the third quarter valued at about $54,000. Finally, BNP Paribas Financial Markets raised its stake in OrthoPediatrics by 60.2% during the third quarter. BNP Paribas Financial Markets now owns 3,288 shares of the company’s stock worth $61,000 after acquiring an additional 1,235 shares in the last quarter. Institutional investors own 69.05% of the company’s stock.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.